Hepatotoxicity of AKR1C3 Inhibitor BAY1128688: Findings from an Early Terminated Phase IIa Trial for the Treatment of Endometriosis.

Autor: Hilpert, Jan1 (AUTHOR) jan.hilpert@bayer.com, Groettrup-Wolfers, Esther1 (AUTHOR), Kosturski, Hristiyan2 (AUTHOR), Bennett, Laura3 (AUTHOR), Barnes, Catriona L. K.3 (AUTHOR), Gude, Kerstin1 (AUTHOR), Gashaw, Isabella1 (AUTHOR), Reif, Stefanie1 (AUTHOR), Steger-Hartmann, Thomas1 (AUTHOR), Scheerans, Christian1 (AUTHOR), Solms, Alexander1 (AUTHOR), Rottmann, Antje1 (AUTHOR), Mao, Guangping1 (AUTHOR), Chapron, Charles4 (AUTHOR)
Zdroj: Drugs in R&D. Sep2023, Vol. 23 Issue 3, p221-237. 17p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje